Global linear accelerator requirements and personalised country recommendations: a cross-sectional, population-based study.
Saved in:
| Title: | Global linear accelerator requirements and personalised country recommendations: a cross-sectional, population-based study. |
|---|---|
| Authors: | Moraes FY; Department of Oncology, Queen's University, Kingston, ON, Canada; Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON, Canada. Electronic address: fydm@queensu.ca., Gouveia AG; Division of Radiation Oncology, McMaster University and Juravinski Cancer Centre, Hamilton, ON, Canada., Freitas Bratti V; Department of Public Health Sciences, Queen's University, Kingston, ON, Canada., Dee EC; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Fernandes Pavoni J; Faculty of Philosophy, Languages and Human Sciences, University of São Paulo, São Paulo, Brazil., Carson LM; Department of Oncology, Queen's University, Kingston, ON, Canada., de Sousa CFPM; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Sullivan R; Institute of Cancer Policy, Global Oncology Group, King's College London, London, UK., Nader Marta G; Department of Oncology, Division of Radiation Oncology, Hospital Sirio Libanês, São Paulo, Brazil., Hopman WM; Department of Public Health Sciences, Queen's University, Kingston, ON, Canada., Booth CM; Department of Oncology, Queen's University, Kingston, ON, Canada; Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON, Canada., Aggarwal A; Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK; Department of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Jemal A; Surveillance and Health Equity Science, American Cancer Society, Atlanta, GA, USA., Hanna TP; Department of Oncology, Queen's University, Kingston, ON, Canada; Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON, Canada., Wilson BE; Department of Oncology, Queen's University, Kingston, ON, Canada; Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON, Canada., Arruda Viani G; Ribeirão Preto Medical School, Department of Medical Imaging, Haematology and Oncology, University of São Paulo, São Paulo, Brazil. |
| Source: | The Lancet. Oncology [Lancet Oncol] 2025 Feb; Vol. 26 (2), pp. 239-248. Date of Electronic Publication: 2025 Jan 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39832518 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Global linear accelerator requirements and personalised country recommendations: a cross-sectional, population-based study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Moraes+FY%22">Moraes FY</searchLink>; Department of Oncology, Queen's University, Kingston, ON, Canada; Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON, Canada. Electronic address: fydm@queensu.ca.<br /><searchLink fieldCode="AU" term="%22Gouveia+AG%22">Gouveia AG</searchLink>; Division of Radiation Oncology, McMaster University and Juravinski Cancer Centre, Hamilton, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Freitas+Bratti+V%22">Freitas Bratti V</searchLink>; Department of Public Health Sciences, Queen's University, Kingston, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Dee+EC%22">Dee EC</searchLink>; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Fernandes+Pavoni+J%22">Fernandes Pavoni J</searchLink>; Faculty of Philosophy, Languages and Human Sciences, University of São Paulo, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Carson+LM%22">Carson LM</searchLink>; Department of Oncology, Queen's University, Kingston, ON, Canada.<br /><searchLink fieldCode="AU" term="%22de+Sousa+CFPM%22">de Sousa CFPM</searchLink>; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Sullivan+R%22">Sullivan R</searchLink>; Institute of Cancer Policy, Global Oncology Group, King's College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Nader+Marta+G%22">Nader Marta G</searchLink>; Department of Oncology, Division of Radiation Oncology, Hospital Sirio Libanês, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Hopman+WM%22">Hopman WM</searchLink>; Department of Public Health Sciences, Queen's University, Kingston, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Booth+CM%22">Booth CM</searchLink>; Department of Oncology, Queen's University, Kingston, ON, Canada; Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Aggarwal+A%22">Aggarwal A</searchLink>; Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK; Department of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Jemal+A%22">Jemal A</searchLink>; Surveillance and Health Equity Science, American Cancer Society, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Hanna+TP%22">Hanna TP</searchLink>; Department of Oncology, Queen's University, Kingston, ON, Canada; Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Wilson+BE%22">Wilson BE</searchLink>; Department of Oncology, Queen's University, Kingston, ON, Canada; Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Arruda+Viani+G%22">Arruda Viani G</searchLink>; Ribeirão Preto Medical School, Department of Medical Imaging, Haematology and Oncology, University of São Paulo, São Paulo, Brazil. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100957246%22">The Lancet. Oncology</searchLink> [Lancet Oncol] 2025 Feb; Vol. 26 (2), pp. 239-248. <i>Date of Electronic Publication: </i>2025 Jan 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lancet+Pub%2E+Group%22">Lancet Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100957246 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-5488 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214702045%22">14702045 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39832518 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S1470-2045(24)00678-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 239 Titles: – TitleFull: Global linear accelerator requirements and personalised country recommendations: a cross-sectional, population-based study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Moraes FY – PersonEntity: Name: NameFull: Gouveia AG – PersonEntity: Name: NameFull: Freitas Bratti V – PersonEntity: Name: NameFull: Dee EC – PersonEntity: Name: NameFull: Fernandes Pavoni J – PersonEntity: Name: NameFull: Carson LM – PersonEntity: Name: NameFull: de Sousa CFPM – PersonEntity: Name: NameFull: Sullivan R – PersonEntity: Name: NameFull: Nader Marta G – PersonEntity: Name: NameFull: Hopman WM – PersonEntity: Name: NameFull: Booth CM – PersonEntity: Name: NameFull: Aggarwal A – PersonEntity: Name: NameFull: Jemal A – PersonEntity: Name: NameFull: Hanna TP – PersonEntity: Name: NameFull: Wilson BE – PersonEntity: Name: NameFull: Arruda Viani G IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2025 Feb Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1474-5488 Numbering: – Type: volume Value: 26 – Type: issue Value: 2 Titles: – TitleFull: The Lancet. Oncology Type: main |
| ResultId | 1 |